Literature DB >> 15039129

Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study.

Demosthenes B Panagiotakos1, Christos Pitsavos, Christina Chrysohoou, Efi Tsetsekou, Charalambos Papageorgiou, George Christodoulou, Christodoulos Stefanadis.   

Abstract

BACKGROUND: Depression is associated with an increase in cardiovascular disease, but the underlying mechanisms are not well understood. The aim of this study was to examine the associations of depressive symptoms with inflammation and coagulation factors related to cardiovascular risk in persons free of cardiovascular disease.
METHODS: A random algorithm was developed and stratified by gender-age and multistage sampling was performed during 2001-2002. In this study, we analysed data from 453 men (19-89 years old) and 400 women (18-84 years old). Inflammation markers were C-reactive protein (CRP), serum amyloid A, white blood cell (WBC) and total platelet counts; and coagulation factors including homocysteine and fibrinogen. Depression was assessed with the Zung Self-Rating Depression Scale (ZDRS range 0-100) after validation for the study population. A ZDRS score of 50 or more classified a person as mildly depressive. Statistical adjustments were made for risk factors (age, gender, smoking, diabetes mellitus, and physical activity level).
RESULTS: Women had significantly higher scores on the Zung depression scale than men (47 +/- 9 vs. 43 +/- 10, p<0.001). Thus, 21% of men and 27% of women had mild depression, while 4% of men and 6% of women had severe depressive symptomatology. The depression scale correlated positively with C-reactive protein levels (p<0.05), white blood cell count (p<0.05), and fibrinogen (p<0.05) in both genders after adjustment for control variables.
CONCLUSION: This study revealed that depression was associated with inflammation and coagulation factors in cardiovascular disease-free people, suggesting a possible pathway leading to an increased frequency of events of coronary heart disease in depressive individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039129     DOI: 10.1016/j.ehj.2004.01.018

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  46 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

2.  Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study.

Authors:  Minxuan Huang; Shaoyong Su; Jack Goldberg; Andrew H Miller; Oleksiy M Levantsevych; Lucy Shallenberger; Pratik Pimple; Bradley Pearce; J Douglas Bremner; Viola Vaccarino
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

3.  Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.

Authors:  Mitchel A Kling; Salvatore Alesci; Gyorgy Csako; Rene Costello; David A Luckenbaugh; Omer Bonne; Roman Duncko; Wayne C Drevets; Husseini K Manji; Dennis S Charney; Philip W Gold; Alexander Neumeister
Journal:  Biol Psychiatry       Date:  2006-12-18       Impact factor: 13.382

Review 4.  Inflammation, coagulation, and the pathway to frailty.

Authors:  Bindu Kanapuru; William B Ershler
Journal:  Am J Med       Date:  2009-07       Impact factor: 4.965

5.  Monocyte chemotactic protein-1 (MCP-1) and growth factors called into question as markers of prolonged psychosocial stress.

Authors:  Ingibjörg H Jonsdottir; Daniel A Hägg; Kristina Glise; Rolf Ekman
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

6.  Association between inflammatory cytokines and the risk of post-stroke depression, and the effect of depression on outcomes of patients with ischemic stroke in a 2-year prospective study.

Authors:  Jian-Tong Jiao; Chao Cheng; Ying-Jun Ma; Jin Huang; Min-Chao Dai; Chen Jiang; Cheng Wang; Jun-Fei Shao
Journal:  Exp Ther Med       Date:  2016-06-30       Impact factor: 2.447

Review 7.  Is depression an inflammatory disorder?

Authors:  Charles L Raison; Andrew H Miller
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

8.  Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.

Authors:  Jean-Eric Ghia; Patricia Blennerhassett; Stephen M Collins
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

9.  Depressive symptomatology, exercise adherence, and fitness are associated with reduced cognitive performance in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Aging Health       Date:  2013-01-31

10.  Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study.

Authors:  G Cizza; F Eskandari; M Coyle; P Krishnamurthy; E C Wright; S Mistry; G Csako
Journal:  Horm Metab Res       Date:  2009-04-30       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.